北美放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型和应用
市场调查报告书
商品编码
1637686

北美放射肿瘤学市场预测至 2031 年 - 区域分析 - 按类型和应用

North America Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application

出版日期: | 出版商: The Insight Partners | 英文 80 Pages | 订单完成后即时交付

价格

2023年北美放射肿瘤市值为40.4723亿美元,预计2031年将达到104.0958亿美元;预计2023年至2031年复合年增长率为12.5%。

癌症盛行率的增加推动了北美放射肿瘤学市场

癌症是对全世界社会产生重大影响的常见健康状况之一。根据世界卫生组织(WHO) 的数据,癌症是全球主要死亡原因,到2023 年,癌症将导致970 万人死亡,新增癌症病例将达到2000 万,预计到2050 年,新增癌症病例将达到约3,500 万。 7.8%、6.9%和6.8%。

癌症盛行率和发病率的不断上升创造了对有效治疗方案的需求。放射治疗是癌症患者不断发展的治疗选择之一,它利用高剂量的辐射(例如 X 射线、伽马射线等)来杀死癌细胞,具有有效的效果。放射治疗用于癌症的早期阶段,各种类型的体外放射治疗用于治疗不同的癌症。例如,近距离放射治疗用于治疗乳癌、子宫颈癌、眼癌、摄护腺癌和头颈癌。同样,全身放射治疗也称为放射性碘,用于治疗甲状腺癌。放射治疗可以在治疗的任何时间使用,并且可以与其他治疗方法结合使用,例如手术、化疗、免疫治疗等。因此,癌症盛行率的增加和肿瘤学放射治疗的发展预计将推动放射肿瘤学市场的成长。

北美放射肿瘤学市场概况

在美国,所有癌症患者都可以广泛使用放射治疗,并且对放射肿瘤科医师的需求不断增加。由于医疗基础设施的发达,这些专业人员的数量也不断增加。儘管如此,美国临床肿瘤学会估计全球约三分之二的癌症患者接受放射治疗作为治疗的一部分。到 2023 年,预计美国每年将有超过 100 万名癌症患者接受放射治疗。政府和医疗机构正在采取多项措施来鼓励采用放射治疗。 2020 年 6 月,美国放射肿瘤学会 (ASTRO) 推出了非转移性子宫颈癌放射治疗的新临床指南。新指南的重点是精确实施放射治疗的步骤和流程。

北美放射肿瘤学市场收入及 2031 年预测(百万美元)

北美放射肿瘤学市场细分

北美放射肿瘤学市场按类型、应用和国家分类。

根据类型,北美放射肿瘤学市场分为体外放射治疗和内照射放射治疗。 2023 年,体外放射治疗领域将占据更大的市场份额。

从应用来看,北美放射肿瘤市场分为乳癌、摄护腺癌、肺癌、头颈癌、子宫颈癌等。 2023 年,乳癌细分市场占据最大的市场份额。

按国家/地区划分,北美放射肿瘤学市场分为美国、加拿大和墨西哥。 2023 年,美国在北美放射肿瘤学市场份额中占据主导地位。

Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Perspective Therapeutics Inc、NTP RADIOISOTOPES、Mallinckrodt Plc、Provision Healthcare 和 Curium 是美国北方运营的一些领先公司美国放射肿瘤学市场。

目录

第 1 章:简介

第 2 章:执行摘要

  • 主要见解

第 3 章:研究方法

  • 二次研究
  • 初步研究
    • 假设表述:
    • 宏观经济因素分析:
    • 显影基数:
    • 数据三角测量:
    • 国家级资料:

第 4 章:北美放射肿瘤学市场格局

  • 概述
  • PEST分析

第 5 章:北美放射肿瘤学市场 - 主要市场动态

  • 市场驱动因素:
    • 癌症盛行率增加
    • 支持放射肿瘤学发展的倡议
  • 市场限制
    • 放射治疗设备成本高
  • 市场机会
    • 放射肿瘤学的策略性倡议
  • 未来趋势
    • 放射肿瘤学的技术进步
  • 驱动因素和限制的影响:

第 6 章:放射肿瘤学市场 - 北美市场分析

  • 放射肿瘤学市场收入,2021-2031

第 7 章:北美放射肿瘤学市场分析 - 按类型

  • 外束放射治疗
  • 内束放射治疗

第 8 章:北美放射肿瘤学市场分析 - 按应用

  • 乳癌
  • 摄护腺癌
  • 肺癌
  • 头颈癌
  • 子宫颈癌
  • 其他的

第 9 章:北美放射肿瘤学市场 - 国家分析

    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥

第 10 章:放射肿瘤学市场 - 产业格局

  • 概述
  • 放射肿瘤学市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 11 章:公司简介

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide (Ion Beam Applications SA)
  • Becton Dickinson and Co
  • Perspective Therapeutics Inc
  • NTP RADIOISOTOPES
  • Mallinckrodt Plc
  • Provision Healthcare
  • Curium

第 12 章:附录

Product Code: BMIRE00031021

The North America radiation oncology market was valued at US$ 4,047.23 million in 2023 and is expected to reach US$ 10,409.58 million by 2031; it is estimated to record a CAGR of 12.5% from 2023 to 2031.

Increasing Prevalence of Cancer Fuels North America Radiation Oncology Market

Cancer is one of the common health conditions significantly impacting society worldwide. According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, accounting for 9.7 million deaths and 20 million new cancer cases in 2023 and it is expected to reach ~35 million new cancer cases by 2050. As per the WHO 2024 report, lung cancer is the most common cancer and leading cause of the death globally followed by colorectal cancer, liver cancer, breast cancer, and stomach cancer accounting for 18.7%, 9.3%, 7.8%, 6.9%, and 6.8% of the total deaths respectively.

The increasing prevalence and incidence of cancer creates demand for effective treatment options. Radiotherapy is one of evolving treatment options for cancer patients with effective outcome which utilizes the high doses of radiation such as X-rays, gamma rays, and others to kill the cancerous cells. Radiotherapy is used in the early stages of cancer and various types of external beam radiotherapy are used for the treatment of different cancers. For instance, brachytherapy is used for the treatment of breast cancer, cervix cancer, eye cancer, prostate cancer, and head & neck cancer. Similarly, Systemic radiation therapy is also known as radioactive iodine and is used for treatment of thyroid cancer. Radiation therapy can be used at any point in the treatment and can be combined with other treatments such as surgery, chemotherapy, immunotherapy and others. Therefore, increasing prevalence of cancer and evolution of radiotherapy in oncology is expected to drive the growth of radiation oncology market.

North America Radiation Oncology Market Overview

Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2023, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy.

North America Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

North America Radiation Oncology Market Segmentation

The North America radiation oncology market is categorized into types, application, and country.

Based on types, the North America radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the North America radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the North America radiation oncology market is segmented into the US, Canada, and Mexico. The US dominated the North America radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, and Curium are some of the leading companies operating in the North America radiation oncology market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Radiation Oncology Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Radiation Oncology Market - Key Market Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 Increasing Prevalence of Cancer
    • 5.1.2 Initiatives to Support Developments in Radiation Oncology
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Radiotherapy Equipment
  • 5.3 Market Opportunities
    • 5.3.1 Strategic Initiatives in Radiation Oncology
  • 5.4 Future Trends
    • 5.4.1 Technological Advancement in Radiation Oncology
  • 5.5 Impact of Drivers and Restraints:

6. Radiation Oncology Market - North America Market Analysis

  • 6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

7. North America Radiation Oncology Market Analysis - by Types

  • 7.1 External Beam Radiation Therapy
    • 7.1.1 Overview
    • 7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Internal Beam Radiation Therapy
    • 7.2.1 Overview
    • 7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Radiation Oncology Market Analysis - by Application

  • 8.1 Breast Cancer
    • 8.1.1 Overview
    • 8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Prostate Cancer
    • 8.2.1 Overview
    • 8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Lung Cancer
    • 8.3.1 Overview
    • 8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Head and Neck Cancer
    • 8.4.1 Overview
    • 8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Cervical Cancer
    • 8.5.1 Overview
    • 8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Radiation Oncology Market - Country Analysis

  • 9.1 North America Radiation Oncology Market Overview
    • 9.1.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.1 United States: Radiation Oncology Market Breakdown, by Types
        • 9.1.1.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.1.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.1.1.4 United States: Radiation Oncology Market Breakdown, by Application
      • 9.1.1.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.1 Canada: Radiation Oncology Market Breakdown, by Types
        • 9.1.1.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.1.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.1.2.4 Canada: Radiation Oncology Market Breakdown, by Application
      • 9.1.1.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
        • 9.1.1.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.1.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.1.3.4 Mexico: Radiation Oncology Market Breakdown, by Application

10. Radiation Oncology Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Radiation Oncology Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Varian Medical Systems Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elekta AB
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Accuray Incorporated
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 IBA Worldwide (Ion Beam Applications SA)
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Becton Dickinson and Co
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Perspective Therapeutics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 NTP RADIOISOTOPES
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Mallinckrodt Plc
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Provision Healthcare
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Curium
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. North America Radiation Oncology Market Segmentation
  • Table 2. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 3. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 4. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 5. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 7. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 8. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 9. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 11. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 12. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 13. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Recent Organic Growth Strategies in Radiation Oncology Market
  • Table 15. Recent Inorganic Growth Strategies in the Radiation Oncology Market
  • Table 16. Glossary of Terms, Radiation Oncology Market

List Of Figures

  • Figure 1. North America Radiation Oncology Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Radiation Oncology Market - Key Market Dynamics
  • Figure 4. Statistics at Glance, Global, 2022
  • Figure 5. Impact Analysis of Drivers and Restraints
  • Figure 6. Radiation Oncology Market Revenue (US$ Million), 2021-2031
  • Figure 7. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
  • Figure 8. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
  • Figure 11. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. North America Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 18. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 19. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Growth Strategies in Radiation Oncology Market